Essential hypertension: Clinical sciences

3,178views

Essential hypertension: Clinical sciences

Watch later

Watch later

Parathyroid hormone
Calcitonin
Vitamin D
Insulin
Glucagon
Diabetes mellitus
Diabetes mellitus: Pathology review
Pancreatic neuroendocrine neoplasms
Hyperparathyroidism
Hypoparathyroidism
Parathyroid disorders and calcium imbalance: Pathology review
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Osteoporosis medications
Hypertrophic cardiomyopathy
Pigmentation skin disorders: Pathology review
Albinism
Thymus histology
Glomerular filtration
Measuring renal plasma flow and renal blood flow
Thyroglossal duct cyst
Bowel obstruction
Platelet plug formation (primary hemostasis)
Anatomy of the abdominal viscera: Kidneys, ureters and suprarenal glands
Anatomy of the perineum
Thiazide and thiazide-like diuretics
Vaginal and vulvar disorders: Pathology review
Alpha-thalassemia
Spleen histology
Fallopian tube and uterus histology
Mammary gland histology
Ovary histology
Brucella
Oral cancer
Oxygen binding capacity and oxygen content
Obstructive lung diseases: Pathology review
Ehrlichia and Anaplasma
Myeloproliferative disorders: Pathology review
Nervous system anatomy and physiology
Hyperkalemia
Dementia: Pathology review
Anatomy of the heart
Anatomy of the coronary circulation
Anatomy clinical correlates: Heart
Anatomy clinical correlates: Mediastinum
Infectious endocarditis: Clinical sciences
Infective endocarditis: Clinical
Endocarditis
Endocarditis: Pathology review
Development of the respiratory system
Adenovirus
Anatomy of the arm
Perinatal infections: Clinical
Dyslipidemias: Pathology review
Acyanotic congenital heart defects: Pathology review
Blood pressure, blood flow, and resistance
ECG basics
Development of the cardiovascular system
Fetal circulation
Calcium channel blockers
Anatomy of the eye
Introduction to the cranial nerves
Cranial nerve pathways
Anatomy of the olfactory (CN I) and optic (CN II) nerves
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy of the glossopharyngeal nerve (CN IX)
Anatomy of the vagus nerve (CN X)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Actinomyces israelii
Clostridium botulinum (Botulism)
Clostridium tetani (Tetanus)
Haemophilus influenzae
Listeria monocytogenes
Mycobacterium tuberculosis (Tuberculosis)
Neisseria meningitidis
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Central nervous system histology
Peripheral nervous system histology
Eye and ear histology
Coxsackievirus
Cytomegalovirus
Eastern and Western equine encephalitis virus
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
JC virus (Progressive multifocal leukoencephalopathy)
Lymphocytic choriomeningitis virus
Measles virus
Mumps virus
Poliovirus
Rabies virus
Varicella zoster virus
West Nile virus
Acute disseminated encephalomyelitis
Central pontine myelinolysis
Multiple sclerosis
Transverse myelitis
Charcot-Marie-Tooth disease
Guillain-Barre syndrome
Adult brain tumors
Neurofibromatosis
Pediatric brain tumors
Pituitary adenoma
Sympathomimetics: Direct agonists
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Cardiac muscle histology
Mesothelioma
Nasal polyps
Nasopharyngeal carcinoma
Pancoast tumor
Superior vena cava syndrome
Cystic fibrosis: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Lung cancer and mesothelioma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Respiratory distress syndrome: Pathology review
Adrenergic antagonists: Presynaptic
Adrenergic receptors
Cholinergic receptors
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympatholytics: Alpha-2 agonists
Introduction to the immune system
Gallbladder disorders: Pathology review
Anatomy of the thyroid and parathyroid glands
Acute coronary syndrome: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to hypertension: Clinical sciences
Coronary artery disease: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Tobacco use: Clinical sciences
Ketone body metabolism
Kidney histology
Ureter, bladder and urethra histology
Bladder exstrophy
Horseshoe kidney
Hydronephrosis
Hypospadias and epispadias
Potter sequence
Renal agenesis
Alport syndrome
Goodpasture syndrome
IgA nephropathy (NORD)
Lupus nephritis
Poststreptococcal glomerulonephritis
Rapidly progressive glomerulonephritis
Amyloidosis
Diabetic nephropathy
Focal segmental glomerulosclerosis (NORD)
Membranoproliferative glomerulonephritis
Membranous nephropathy
Minimal change disease
Acute tubular necrosis
Renal papillary necrosis
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Postrenal azotemia
Prerenal azotemia
Renal azotemia
Chronic kidney disease
Kidney stones
Renal tubular acidosis
Angiomyolipoma
Medullary cystic kidney disease
Medullary sponge kidney
Multicystic dysplastic kidney
Polycystic kidney disease
Beckwith-Wiedemann syndrome
Nephroblastoma (Wilms tumor)
Non-urothelial bladder cancers
Renal cell carcinoma
Transitional cell carcinoma
WAGR syndrome
Neurogenic bladder
Posterior urethral valves
Urinary incontinence
Vesicoureteral reflux
Renal artery stenosis
Renal cortical necrosis
Metabolic acidosis
Metabolic alkalosis
Respiratory acidosis
Respiratory alkalosis
Hypercalcemia
Hypermagnesemia
Hypernatremia
Hyperphosphatemia
Hypocalcemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypophosphatemia
Congenital renal disorders: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Urinary tract infections: Pathology review
Kidney stones: Pathology review
Renal failure: Pathology review
Renal tubular acidosis: Pathology review
Renal tubular defects: Pathology review
Renal and urinary tract masses: Pathology review
Urinary incontinence: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Appendicitis
Abdominal hernias
Inguinal hernias: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Ventral and incisional hernias: Clinical sciences
Inguinal hernia
Femoral hernia
Acute pancreatitis: Clinical sciences
Cholecystitis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Anticoagulants: Warfarin
Factor V Leiden

Decision-Making Tree

Transcript

Watch video only

Essential hypertension is a chronic condition that occurs when an individual’s blood pressure is persistently elevated, without an identifiable cause. It’s a significant contributor to the development of atherosclerotic cardiovascular disease, or ASCVD. Diagnosis also includes assessing for the presence of other ASCVD risk factors; ruling out secondary causes with screening history, physical and labs; and classifying your patient’s blood pressure readings into one of the three groups: Elevated Blood Pressure, formerly known as pre-hypertension, with a systolic blood pressure between 120 and 129 and diastolic blood pressure less than 80 mmHg; Stage 1 hypertension with a systolic blood pressure between 130 and 139 or diastolic blood pressure between 80 to 89 mmHg; or Stage 2 hypertension with a systolic blood pressure greater than or equal to 140 or diastolic blood pressure greater than or equal to 90 mmHg.

Now, if you suspect essential hypertension, perform an ABCDE assessment to determine if the patient is stable or unstable. If unstable, stabilize their airway, breathing, and circulation. Additionally, obtain IV access, provide supplemental oxygen, and put them on continuous vital sign monitoring including blood pressure, heart rate, and pulse oximetry.

Next, proceed with a focused history and physical examination and obtain CMP, troponin, and urinalysis. Also, don't forget to order an ECG and chest X-ray. Together, these will help you identify target organ damage.

Now, your patient might report vision changes, headache, shortness of breath, chest pain, or back pain. Their physical exam may reveal a systolic blood pressure of 180 or a diastolic blood pressure of 120 or greater. Additionally, the exam might reveal altered mental status, respiratory crackles, or decreased peripheral pulses.

As for labs, you may see an elevated creatinine on CMP, an elevated troponin, and proteinuria on the urinalysis. The ECG might show ST segment changes, atrial fibrillation, or left ventricular hypertrophy, while the chest X-ray may reveal a widened mediastinum* or pulmonary edema**.

These findings indicate target organ damage. The combination of severely elevated blood pressure, often with systolic blood pressure over 180 or diastolic blood pressure over 120, and evidence of target organ damage indicates Hypertensive Emergency.

Treatment consists of IV antihypertensive medications, such as certain beta-blockers, like labetalol; calcium channel blockers, like nicardipine; or vasodilators, like hydralazine. Here’s a high yield fact! When there’s severely elevated blood pressure without evidence of target organ damage, that’s Hypertensive Urgency. In these patients, blood pressure can be reduced gradually with oral antihypertensives.

Okay, let’s go back and look at stable patients. If your patient is stable, proceed with a focused history and physical exam. Your patient might be asymptomatic, or could report non-specific symptoms like nose bleeds or headaches. Additionally, there might be a family history of hypertension. They may also have other ASCVD risk factors, including obesity, physical inactivity, tobacco use, hyperlipidemia, and diabetes. They may also have other comorbidities like coronary artery disease, heart failure, chronic kidney disease, and obstructive sleep apnea.

And don’t forget to assess for use of medications that can cause high blood pressure, such as contraceptives, corticosteroids, and NSAIDs!

Finally, let’s take a look at the physical exam. Be sure to check the blood pressure in both arms and listen for murmurs, gallops, and bruits to screen for cardiovascular abnormalities!

If the blood pressure is greater than 120 over 80 mmHg, you should suspect either elevated blood pressure or hypertension.

Ok, now that you suspect this, order screening labs, which include a TSH, CBC, CMP, lipid panel, and urinalysis, as well as an ECG. These will help identify other cardiovascular risk factors, assess for target-organ damage, and rule out secondary causes of hypertension, such as hyperthyroidism, polycythemia vera, hypercalcemia, and renal disease.

If it’s not secondary, TSH will typically be normal, while the remaining labs might reveal abnormalities due to comorbidities. For example, CBC may show anemia due to chronic kidney disease; while CMP might reveal an elevated creatinine, indicating kidney injury, or elevated glucose, indicating diabetes. Additionally, lipid panel may show elevated low-density lipoprotein, elevated triglycerides, as well as decreased high-density lipoprotein, which indicates hyperlipidemia; while urinalysis might show proteinuria, suggestive of kidney injury.

Finally, the ECG can help you evaluate cardiac, like left ventricular hypertrophy or ischemic heart disease.

After considering secondary causes and end-organ damage, your next step is to classify the patient’s blood pressure.”

If systolic blood pressure is between 120 and 129 and diastolic blood pressure is less than 80, diagnose Elevated Blood Pressure.

Sources

  1. "ASCVD Risk Estimator Plus application" American College of Cardiology (2023)
  2. "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines" Hypertension (2018)
  3. "I have a patient with hypertension. How do I determine the cause?" Symptom to Diagnosis an Evidence Based Guide, 4th ed. (2020)
  4. "Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: filling a guidance gap: a scientific statement from the American Heart Association" Hypertension (2021)
  5. "Molecular Interactions of Arterial Hypertension in Its Target Organs" Int J Mol Sci (2021)
  6. "Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline" Circulation (2018)
  7. "Hypertension" CDIM CORE MEDICINE CLERKSHIP CURRICULUM GUIDE, 4th ed. (2020)